WASHINGTON, United States (AFP) — The United States will “immediately” make supplies of material to make vaccines, as well as therapeutics, tests, ventilators and protective equipment available to India, facing a Covid-19 surge, the White House said Sunday.
“The United States has identified sources of specific raw material urgently required for Indian manufacture of the Covishield vaccine that will immediately be made available for India,” a White House statement said.
It listed other initiatives Washington is taking to help India battle its surge, but did not mention sending surplus AstraZeneca vaccine, as a backlash grows over the fate of the US stockpile of some 30 million doses which have not been approved for use.
© Agence France-Presse